Table of Content

1 Study Coverage
1.1 Human Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccines Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Human Vaccines Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Human Vaccines Market by Region
1.4.1 Global Human Vaccines Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Human Vaccines Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Human Vaccines Revenue by Players
2.1.1 Global Human Vaccines Revenue by Players (2019-2024)
2.1.2 Global Human Vaccines Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Human Vaccines Revenue in 2024
2.2 Global Human Vaccines Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Human Vaccines Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Merck
3.1.1 Merck Information
3.1.2 Merck Overview
3.1.3 Merck Human Vaccines Revenue and Gross Margin (2019-2024)
3.1.4 Merck Related Developments
3.2 Sinovac
3.2.1 Sinovac Information
3.2.2 Sinovac Overview
3.2.3 Sinovac Human Vaccines Revenue and Gross Margin (2019-2024)
3.2.4 Sinovac Related Developments
3.3 Emergent Biosolutions
3.3.1 Emergent Biosolutions Information
3.3.2 Emergent Biosolutions Overview
3.3.3 Emergent Biosolutions Human Vaccines Revenue and Gross Margin (2019-2024)
3.3.4 Emergent Biosolutions Related Developments
3.4 Seqirus
3.4.1 Seqirus Information
3.4.2 Seqirus Overview
3.4.3 Seqirus Human Vaccines Revenue and Gross Margin (2019-2024)
3.4.4 Seqirus Related Developments
3.5 Bavarian Nordic
3.5.1 Bavarian Nordic Information
3.5.2 Bavarian Nordic Overview
3.5.3 Bavarian Nordic Human Vaccines Revenue and Gross Margin (2019-2024)
3.5.4 Bavarian Nordic Related Developments
3.6 Bharat Biotech
3.6.1 Bharat Biotech Information
3.6.2 Bharat Biotech Overview
3.6.3 Bharat Biotech Human Vaccines Revenue and Gross Margin (2019-2024)
3.6.4 Bharat Biotech Related Developments
3.7 GlaxoSmithKline (GSK)
3.7.1 GlaxoSmithKline (GSK) Information
3.7.2 GlaxoSmithKline (GSK) Overview
3.7.3 GlaxoSmithKline (GSK) Human Vaccines Revenue and Gross Margin (2019-2024)
3.7.4 GlaxoSmithKline (GSK) Related Developments
3.8 Biological E. Limited
3.8.1 Biological E. Limited Information
3.8.2 Biological E. Limited Overview
3.8.3 Biological E. Limited Human Vaccines Revenue and Gross Margin (2019-2024)
3.8.4 Biological E. Limited Related Developments
3.9 Pfizer
3.9.1 Pfizer Information
3.9.2 Pfizer Overview
3.9.3 Pfizer Human Vaccines Revenue and Gross Margin (2019-2024)
3.9.4 Pfizer Related Developments
3.10 Panacea Biotec
3.10.1 Panacea Biotec Information
3.10.2 Panacea Biotec Overview
3.10.3 Panacea Biotec Human Vaccines Revenue and Gross Margin (2019-2024)
3.10.4 Panacea Biotec Related Developments
3.11 Sanofi Pasteur
3.11.1 Sanofi Pasteur Information
3.11.2 Sanofi Pasteur Overview
3.11.3 Sanofi Pasteur Human Vaccines Revenue and Gross Margin (2019-2024)
3.11.4 Sanofi Pasteur Related Developments
4 Global Human Vaccines Market Insights
4.1 Global Human Vaccines Market Revenue 2019-2024
4.2 Global Human Vaccines Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Human Vaccines Revenue by Type
5.2 Global Human Vaccines Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Human Vaccines Revenue by Application
6.2 Global Human Vaccines Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Human Vaccines Market Size by Type
7.1.1 Americas Human Vaccines Revenue by Type (2019-2024)
7.1.2 Americas Human Vaccines Revenue Share by Type (2019-2024)
7.2 Americas Human Vaccines Market Size by Application
7.2.1 Americas Human Vaccines Revenue by Application (2019-2024)
7.2.2 Americas Human Vaccines Revenue Share by Application (2019-2024)
7.3 Americas Human Vaccines Market Size by Country
7.3.1 Americas Human Vaccines Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Human Vaccines Market Size by Type
8.1.1 Europe Human Vaccines Revenue by Type (2019-2024)
8.1.2 Europe Human Vaccines Revenue Share by Type (2019-2024)
8.2 Europe Human Vaccines Market Size by Application
8.2.1 Europe Human Vaccines Revenue by Application (2019-2024)
8.2.2 Europe Human Vaccines Revenue Share by Application (2019-2024)
8.3 Europe Human Vaccines Market Size by Country
8.3.1 Europe Human Vaccines Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Human Vaccines Market Size by Type
9.1.1 Asia Pacific Human Vaccines Revenue by Type (2019-2024)
9.1.2 Asia Pacific Human Vaccines Revenue Share by Type (2019-2024)
9.2 Asia Pacific Human Vaccines Market Size by Application
9.2.1 Asia Pacific Human Vaccines Revenue by Application (2019-2024)
9.2.2 Asia Pacific Human Vaccines Revenue Share by Application (2019-2024)
9.3 Asia Pacific Human Vaccines Market Size by Region
9.3.1 Asia Pacific Human Vaccines Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Human Vaccines Market Size by Type
10.1.1 Middle East and Africa Human Vaccines Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Human Vaccines Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Human Vaccines Market Size by Application
10.2.1 Middle East and Africa Human Vaccines Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Human Vaccines Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Human Vaccines Market Size by Country
10.3.1 Middle East and Africa Human Vaccines Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Human Vaccines Industry Trends
11.2 Human Vaccines Market Drivers
11.3 Human Vaccines Market Challenges
11.4 Human Vaccines Market Restraints
12 Human Vaccines Forecasted Market Size by Type
12.1 Global Human Vaccines Forecasted Revenue by Type
12.2 Global Human Vaccines Forecasted Market Size Growth by Type 2024-2030
13 Human Vaccines Forecasted Market Size by Application
13.1 Global Human Vaccines Forecasted Revenue by Application
13.2 Global Human Vaccines Forecasted Market Size Growth by Application 2024-2030
14 Global Human Vaccines Market Forecasts
14.1 Global Human Vaccines Market Revenue Forecasts 2024-2030
14.2 Global Human Vaccines Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer